ArticleAntimicrobial agents and chemotherapy2020
Dynamics of
Open access · greenAbstract read
In one paragraph
Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.
- Prevalence and clonal diversity of carbapenem-resistant Klebsiella pneumoniae causing neonatal infections: A systematic review of 128 articles across 30 countries.PLoS medicine · 2023Pooled it
- Genomics of Hospital-Associated Brazilian Multidrug-Resistant Klebsiella pneumoniae: Abundance of Resistance and Virulence Genes and Mosaicism of the blaCurrent microbiology · 2026Article
- Closely related ST11Frontiers in immunology · 2026Article
- New Insights inAntibiotics (Basel, Switzerland) · 2025Article
- Use of MALDI-TOF VITEK MS for rapid and efficient identification of KPC-type carbapenemases in Enterobacterales carrying the Tn4401a transposon.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025Article
- Mobile genetic elements encoding antibiotic resistance genes and virulence genes inFrontiers in microbiology · 2025Review
- VIM-1-producing Enterobacter asburiae with mobile colistin resistance genes from wastewaters.BMC genomics · 2024Article
- pQEB1: a hospital outbreak plasmid lineage carryingMicrobial genomics · 2024Article
- From Species to Genes: A New Diagnostic Paradigm.Antibiotics (Basel, Switzerland) · 2024Review
- Emergence of Carbapenemase Genes in Gram-Negative Bacteria Isolated from the Wastewater Treatment Plant in A Coruña, Spain.Antibiotics (Basel, Switzerland) · 2024Article
- Developing a framework for tracking antimicrobial resistance gene movement in a persistent environmental reservoir.npj antimicrobials and resistance · 2024Article
- First Detection of International High-RiskTransboundary and emerging diseases · 2024Article
- Plasmid genomic epidemiology ofAntimicrobial agents and chemotherapy · 2023Article
- Characterization ofAntibiotics (Basel, Switzerland) · 2023Article
- Worldwide Dissemination ofAntibiotics (Basel, Switzerland) · 2023Review
- Identification ofAntibiotics (Basel, Switzerland) · 2023Article
- Microbial epidemiology and clinical risk factors of carbapenemase-producing Enterobacterales amongst Irish patients from first detection in 2009 until 2020.Infection prevention in practice · 2022Article
- Epidemiology of Plasmids inAntibiotics (Basel, Switzerland) · 2022Article
- The Changing Epidemiology of Carbapenemase-Producing Enterobacterales.Rambam Maimonides medical journal · 2022Article
- Conjugative transfer of multi-drug resistance IncN plasmids from environmental waterborne bacteria toFrontiers in microbiology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 6 institutions in 2 countries.
Ana M RadaDepartment of Microbiology and Parasitology, Bacteria and Cancer Group, Universidad de Antioquia, Medellín, Colombia ana.rada@colmayor.edu.co Cesar.Arias@uth.tmc.edu.ORCID 0000-0002-9624-4776
Elsa De La CadenaResearch Group on Antimicrobial Resistance and Hospital Epidemiology, Universidad El Bosque, Bogotá, Colombia.
Carlos AgudeloClinica Universitaria Bolivariana, School of Health Sciences, Universidad Pontificia Bolivariana, Medellín, Colombia.
Cesar CapatazFundación Clínica del Norte, Bello, Colombia.
Nataly OrozcoDepartment of Microbiology and Parasitology, Bacteria and Cancer Group, Universidad de Antioquia, Medellín, Colombia.
Cristian PallaresResearch Group on Antimicrobial Resistance and Hospital Epidemiology, Universidad El Bosque, Bogotá, Colombia.
An Q DinhDivision of infectious Diseases and Center for Antimicrobial Resistance and Microbial Genomics, UTHealth, McGovern Medical School, Houston, Texas, USA.
Diana PanessoDivision of infectious Diseases and Center for Antimicrobial Resistance and Microbial Genomics, UTHealth, McGovern Medical School, Houston, Texas, USA.
Rafael RíosDivision of infectious Diseases and Center for Antimicrobial Resistance and Microbial Genomics, UTHealth, McGovern Medical School, Houston, Texas, USA.
Lorena DiazDivision of infectious Diseases and Center for Antimicrobial Resistance and Microbial Genomics, UTHealth, McGovern Medical School, Houston, Texas, USA.
Adriana CorreaUniversidad Santiago de Cali, Facultad de Ciencias Básicas, Cali, Colombia.
Blake M HansonDivision of infectious Diseases and Center for Antimicrobial Resistance and Microbial Genomics, UTHealth, McGovern Medical School, Houston, Texas, USA.
Maria V VillegasResearch Group on Antimicrobial Resistance and Hospital Epidemiology, Universidad El Bosque, Bogotá, Colombia.
Cesar A AriasDivision of infectious Diseases and Center for Antimicrobial Resistance and Microbial Genomics, UTHealth, McGovern Medical School, Houston, Texas, USA ana.rada@colmayor.edu.co Cesar.Arias@uth.tmc.edu.
Eliana RestrepoDepartment of Microbiology and Parasitology, Bacteria and Cancer Group, Universidad de Antioquia, Medellín, Colombia.
Universidad El Bosque · COUniversidad de Antioquia · COThe University of Texas Health Science Center at Houston · USUniversidad del Norte · COUniversidad Pontificia Bolivariana · COUniversidad Santiago de Cali · CO
Funding
Project 3: Functional Microbiome and Host Signatures in Transition from Commensal to pathogenP01AI152999 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ARIAS, CESAR AUGUSTO · 2020 to 2025
$12.0MThe LiaFSR system and antimicrobial peptide resistance in enterococciR01AI134637 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Cesar Augusto Arias · 2018 to 2026
$3.7MMolecular Mechanisms Of Daptomycin Resistance In EnterococciR01AI093749 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ARIAS, CESAR AUGUSTO · 2011 to 2015
$1.9MPOR Program on Genomic Prediction of Antimicrobial Resistance in VREK24AI121296 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ARIAS, CESAR AUGUSTO · 2016 to 2025
$1.5MMolecular basis of the cefazolin inoculum effectR21AI143229 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ARIAS, CESAR AUGUSTO · 2019 to 2020
$442kNIAID NIH HHS K24 AI121296NIAID NIH HHS P01 AI152999NIAID NIH HHS R01 AI093749NIAID NIH HHS R01 AI134637NIAID NIH HHS R21 AI143229
Abstract
Carbapenem-resistant
Indexed as
Klebsiella InfectionsKlebsiella pneumoniaeBacterial Proteinsbeta-LactamasesCarbapenemsColombiaHumansInfant, NewbornPlasmidsBacterial Proteinsbeta-LactamasesCarbapenemsblaKPC-2ColombiaEnterobacteralesIncN plasmidKlebsiella pneumoniae non-CG258outbreakwhole-genome sequencing
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.